Q3 2020 Holdings
Filed 2020-11-13 | 12 holdings | $877.6K | 13F-HR/A | View on SEC ↗ · Holdings Table ↗
Amended (2020-11-19) | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Autolus Therapeutics Limited(AUTL) | Common | 05280R100 | $463.0K | 39,740 | 52.8% |
| Repare Therapeutics, Inc.(RPTX) | Common | 760273102 | $73.5K | 2,388,337 | 8.4% |
| Tcr2 Therapeutics, Inc. | Common | 87808K106 | $68.5K | 3,370,982 | 7.8% |
| Harpoon Therapeutics, Inc. | Common | 41358P106 | $66.2K | 3,898,422 | 7.5% |
| iTeos Therapeutics, Inc.(5E7) | Common | 46565G104 | $58.1K | 2,355,557 | 6.6% |
| Epizyme, Inc.(EPZMEUR)A | Common | 29428V104 | $34.1K | 2,854,737 | 3.9% |
| MEI Pharma, Inc. | Common | 552798202 | $31.6K | 10,137,859 | 3.6% |
| Turning Point Therapeutics, Inc. | Common | 90041T108 | $27.0K | 308,686 | 3.1% |
| ADC Therapeutics, Inc.(ADCT) | Common | H0036K147 | $17.8K | 539,648 | 2.0% |
| G1 Therapeutics, Inc.(GTHXEUR) | Common | 3621LQ109 | $16.4K | 1,423,794 | 1.9% |
| YmAbs Therapeutics, Inc.(YMABUSD) | Common | 984241109 | $12.9K | 337,291 | 1.5% |
| Merus N.V. | Common | N5749R100 | $8.4K | 700,879 | 1.0% |